Legal & Regulatory Compliance

FSA Compliance Statement

Trades Pain is fully committed to complying with all applicable United Kingdom laws and regulations governing the sale of CBD products.

All CBD products supplied and sold by Trades Pain are manufactured in accordance with current UK regulatory requirements and are registered in line with the UK Food Standards Agency (FSA) Novel Foods framework where required.

Our manufacturing partners operate to high quality and safety standards, and all relevant products are submitted under the FSA Novel Foods authorisation process. We only retail products that meet current regulatory guidance and compliance requirements applicable within England, Wales and Scotland.

Product Safety & Quality Standards

All products supplied to Trades Pain:

  • Are produced by reputable manufacturers operating under appropriate quality control systems
  • Are tested for cannabinoid content and compliance with UK THC limits (no more than 1mg THC per container)
  • Are accompanied by relevant batch documentation and third-party laboratory testing where applicable
  • Comply with current UK labelling and consumer safety requirements

We maintain ongoing due diligence procedures to ensure continued compliance with evolving regulatory standards.

THC & Legal Limits

In accordance with UK law:

  • Products sold by Trades Pain contain no more than 1mg of controlled cannabinoids per finished product container.
  • Our products are non-psychoactive and not intended to produce any intoxicating effects.

Age Restrictions

CBD products sold by Trades Pain are intended for adults aged 18 and over. We operate an age-verification system to prevent underage access to our website and products.

Medical Disclaimer

Products sold by Trades Pain are food supplements and are not intended to diagnose, treat, cure or prevent any disease.

Customers should consult a healthcare professional before use if they are:

  • Pregnant or breastfeeding
  • Taking medication
  • Under medical supervision
  • Managing a medical condition

Ongoing Regulatory Monitoring

UK CBD regulations are subject to change. Trades Pain actively monitors regulatory developments and will adapt product offerings and compliance procedures accordingly to ensure continued lawful operation.